home / stock / nuvb / nuvb short
Short Information | Nuvation Bio Inc. Class A (NYSE:NUVB)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 271,326 |
Total Actual Volume | 40,970,043 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 13,566 |
Average Short Percentage | 0.69% |
Is there a NUVB Short Squeeze or Breakout about to happen?
See the NUVB Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-03-2024 | $3.01 | $2.93 | $3.07 | $2.91 | 820,836 | 15,267 | 1.86% |
07-02-2024 | $3.15 | $2.98 | $3.2 | $2.94 | 1,589,267 | 80,153 | 5.04% |
07-01-2024 | $3.01 | $3.16 | $3.16 | $2.88 | 2,333,453 | 12,631 | 0.54% |
06-28-2024 | $3.08 | $2.92 | $3.215 | $2.91 | 10,440,211 | 76,206 | 0.73% |
06-27-2024 | $3.09 | $3.04 | $3.176 | $3.02 | 1,500,791 | 7,454 | 0.5% |
06-26-2024 | $3.146 | $2.99 | $3.248 | $2.98 | 1,638,033 | 2,431 | 0.15% |
06-25-2024 | $3 | $3.04 | $3.04 | $2.9 | 1,882,710 | 7,156 | 0.38% |
06-24-2024 | $3.09 | $3 | $3.15 | $2.91 | 1,900,652 | 29,583 | 1.56% |
06-21-2024 | $3.04 | $3.05 | $3.07 | $2.965 | 3,327,973 | 4,980 | 0.15% |
06-20-2024 | $2.9 | $3.03 | $3.055 | $2.9 | 1,418,097 | 3,339 | 0.24% |
06-18-2024 | $2.9 | $2.9 | $2.94 | $2.84 | 1,065,112 | 3,083 | 0.29% |
06-17-2024 | $3.01 | $2.93 | $3.04 | $2.91 | 839,098 | 7,950 | 0.95% |
06-14-2024 | $3.16 | $3.02 | $3.26 | $2.985 | 1,358,312 | 2,762 | 0.2% |
06-13-2024 | $2.92 | $2.99 | $3.015 | $2.88 | 840,726 | 2,214 | 0.26% |
06-12-2024 | $2.98 | $2.92 | $3.025 | $2.88 | 856,408 | 1,936 | 0.23% |
06-11-2024 | $2.87 | $2.85 | $2.968 | $2.81 | 1,318,799 | 778 | 0.06% |
06-10-2024 | $2.76 | $2.9 | $3.015 | $2.76 | 1,672,038 | 2,989 | 0.18% |
06-07-2024 | $2.86 | $2.77 | $2.87 | $2.725 | 1,572,990 | 5,269 | 0.33% |
06-06-2024 | $2.79 | $2.91 | $2.975 | $2.7898 | 2,182,544 | 3,057 | 0.14% |
06-05-2024 | $2.63 | $2.8 | $2.82 | $2.57 | 2,411,993 | 2,088 | 0.09% |
News, Short Squeeze, Breakout and More Instantly...
Nuvation Bio Inc. Class A Company Name:
NUVB Stock Symbol:
NYSE Market:
Nuvation Bio Inc. Class A Website:
Tumors shrank in 91% of taletrectinib-treated patients with advanced ROS1-positive NSCLC who were ROS1 TKI-naïve and 52% of those who were ROS1 TKI-pretreated in the study Responses were durable with long-term follow-up; 71% of TKI-naïve patients were still progression-free at t...
Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, announced today that David Hung, M.D., Founder, President, and Chief Executive Officer of Nu...
Acquisition of AnHeart Therapeutics transformed Nuvation Bio into a late-stage, global oncology company with potential to become a commercial organization by the end of 2025 Updated data from the pivotal Phase 2 TRUST-I clinical study of taletrectinib, a ROS1 inhibitor, to be presented at...